Volume 11, Issue 1 (5-1997)                   Med J Islam Repub Iran 1997 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
VODJGANI M, NASSIRI ZADEH F, HADJATI J, AKBARlAN M. ANTINEUTROPHIL CY TOPLASMIC AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS. Med J Islam Repub Iran 1997; 11 (1) :15-17
URL: http://mjiri.iums.ac.ir/article-1-1135-en.html
ANTINEUTROPHIL CY TOPLASMIC AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS
M VODJGANI , F NASSIRI ZADEH , J HADJATI , M AKBARlAN
From the Dept. of lmmunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Abstract:   (4371 Views)
Antineutrophil cytoplasmic autoantibodies (ANCA) were first described in patients with necrotizing glomerulonephritis. The original observation passed unnoticed until an association was made between ANCA and active Wegener's granulomatosis. Since then, tremendous progress has been made in elucidating the association between ANCA subtypes and clinicopathologic syndromes, and the potential pathologic role of ANCA in vascular inflammation. The gold standard method for ANCA detection is indirect immunofluorescence (IIF) microscopy of ethanol-fixed cells. By this technique two general patterns of ANCA, acytoplasmic pattern (c-ANCA) and a perinuclear pattern (P-ANCA) can be identifed. Recently some reports have been published concerning the prevalence, subtypes, role and specificity of ANCA.ln this study we searched for ANCA prevalence, subtypes, and its relationship with disease activity in SLE patients by IIF technique. Our results showed that all normal subjects were ANCA negative, while at least 50% of patients were ANCA positive (majority c-ANCA type). Statistical analysis revealed that there is no correlation between the presence of ANCA and disease activity (p<0.01).
Full-Text [PDF 341 kb]   (1437 Downloads)    
Type of Study: Original Research | Subject: Immunology
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.